# A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

> **NCT07212322** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 24 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Idiopahic Inflammatory Myopathies
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Sjögren's Syndrome
- Antiphospholipid Syndrome
- Immune Thrombocytopenia
- Systemic Sclerosis

## Interventions

- **DRUG:** CD19 UCAR-T cells

## Key facts

- **NCT ID:** NCT07212322
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2027-05-20
- **Final completion:** 2027-07-20
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07212322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07212322, "A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07212322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*